SCYNEXIS INC (SCYX)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
---|---|---|---|---|
Total revenue | 1,364 | - | - | |
Selling, general and administrative | - | 3,726 | 2,907 | |
Research and development | - | 5,141 | 8,073 | |
Total operating expenses | - | 8,867 | 10,980 | |
Total revenue | - | 257 | 660 | |
Loss from operations | -9,561 | -8,610 | -10,320 | |
Interest income | 510 | 776 | 1,020 | |
Interest expense | - | 173 | 213 | |
Derivative liability fair value adjustment | - | - | - | |
Warrant liabilities fair value adjustment | -2,166 | -2,928 | -6,751 | |
Amortization of debt issuance costs and discount | - | 312 | 441 | |
Total other (income) expense | 2,676 | 3,219 | 7,117 | |
Loss before taxes | -6,885 | -5,391 | -3,203 | |
Income tax expense | - | - | -395 | |
Net loss | -6,885 | -5,391 | -2,808 | |
Earnings per share, basic, total | -0.14 | -0.11 | -0.06 | |
Net (loss) income per share - diluted | -0.14 | -0.11 | -0.06 | |
Weighted average common shares outstanding, basic | 49,748,919 | 49,435,500 | 48,618,693 | |
Weighted average common shares outstanding, diluted | 49,748,919 | 49,435,500 | 48,618,693 |